Lung cancer classification: Difference between revisions
Trushatank (talk | contribs) |
Trushatank (talk | contribs) No edit summary |
||
Line 34: | Line 34: | ||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ | ||
! colspan="2" | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" ! | WHO Classification of Lung Tumors | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histological type | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histological type | ||
Line 92: | Line 92: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Large cell carcinoma of the lung|Large cell carcinoma]]''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Large cell carcinoma of the lung|Large cell carcinoma]]''' | ||
| | | | ||
* N/A | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Adenosquamous carcinoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Adenosquamous carcinoma''' | ||
| | | | ||
* N/A | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Sarcomatoid carcinoma of the lung|Sarcomatoid carcinomas]]''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Sarcomatoid carcinoma of the lung|Sarcomatoid carcinomas]]''' | ||
Line 136: | Line 138: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hamartoma|'''Pulmonary hamartoma''']] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hamartoma|'''Pulmonary hamartoma''']] | ||
| | | | ||
* N/A | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Chondroma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Chondroma''' | ||
| | | | ||
* N/A | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''PEComatous tumors''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''PEComatous tumors''' | ||
Line 149: | Line 153: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Congenital peribronchial myofibroblastic tumor''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Congenital peribronchial myofibroblastic tumor''' | ||
| | | | ||
* N/A | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Diffuse pulmonary lymphangiomatosis''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Diffuse pulmonary lymphangiomatosis''' | ||
| | | | ||
* N/A | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Inflammatory myofibroblastic tumor | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Inflammatory myofibroblastic tumor''' | ||
| | | | ||
* N/A | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vascular tumor|'''Epithelioid hemangioendothelioma''']] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vascular tumor|'''Epithelioid hemangioendothelioma''']] | ||
| | | | ||
* N/A | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pleuropulmonary blastoma|'''Pleuropulmonary blastoma''']] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pleuropulmonary blastoma|'''Pleuropulmonary blastoma''']] | ||
| | | | ||
* N/A | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Synovial sarcoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Synovial sarcoma''' | ||
| | | | ||
* N/A | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Pulmonary artery intimal sarcoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Pulmonary artery intimal sarcoma''' | ||
| | | | ||
* N/A | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Pulmonary myxoid sarcoma with EWSR1–CREB1 translocation''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Pulmonary myxoid sarcoma with EWSR1–CREB1 translocation''' | ||
| | | | ||
* N/A | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | Myoepithelial tumors | | style="background: #DCDCDC; padding: 5px; text-align: center;" | '''Myoepithelial tumors''' | ||
| | | | ||
* Myoepithelioma | * Myoepithelioma | ||
Line 180: | Line 192: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Extranodal marginal zone lymphomas of mucosa-associated Lymphoid tissue (MALT lymphoma)''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Extranodal marginal zone lymphomas of mucosa-associated Lymphoid tissue (MALT lymphoma)''' | ||
| | | | ||
* N/A | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Diffuse large cell lymphoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Diffuse large cell lymphoma''' | ||
| | | | ||
* N/A | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lymphomatoid granulomatosis|'''Lymphomatoid granulomatosis''']] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lymphomatoid granulomatosis|'''Lymphomatoid granulomatosis''']] | ||
| | | | ||
* N/A | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Intravascular large B cell lymphoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Intravascular large B cell lymphoma''' | ||
| | | | ||
* N/A | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Pulmonary Langerhans cell histiocytosis''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Pulmonary Langerhans cell histiocytosis''' | ||
| | | | ||
* N/A | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Erdheim–Chester disease''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Erdheim–Chester disease''' | ||
| | | | ||
* N/A | |||
|- | |- | ||
! colspan="2" style="background: #707070; color: #FFFFFF; text-align: center;" |'''Tumors of ectopic origin''' | ! colspan="2" style="background: #707070; color: #FFFFFF; text-align: center;" |'''Tumors of ectopic origin''' | ||
Line 205: | Line 223: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Intrapulmonary thymoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Intrapulmonary thymoma''' | ||
| | | | ||
* N/A | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Melanoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Melanoma''' | ||
| | | | ||
* N/A | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Meningioma, NOS''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Meningioma, NOS''' | ||
| | | | ||
* N/A | |||
|} | |} | ||
Revision as of 18:36, 19 February 2019
Lung cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Lung cancer classification On the Web |
American Roentgen Ray Society Images of Lung cancer classification |
Risk calculators and risk factors for Lung cancer classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kim-Son H. Nguyen M.D. Cafer Zorkun, M.D., Ph.D. [2] Rim Halaby, M.D. [3] Dildar Hussain, MBBS [4]
Overview
Primary lung cancers may be classified into small cell lung cancer (~15%) and non small cell lung cancer (~85%). Non small cell lung cancer are a heterogenous group of lung cancers that are often grouped together because they share similar clinical features (e.g. prognosis and management). The 2004 WHO histological classification of tumors of the lung categorized lung tumors into malignant epithelial tumors, benign epithelial tumors, lymphoproliferative tumors, miscellaneous tumors, and metastatic tumors.
Classification
Primary lung cancers may be classified into two main categories:[1]
- Small cell lung cancer (~15%)
- Non small cell lung cancer (~85%).
Lung Cancer | |||||||||||||||
Small cell lung cancer (~15%) | |||||||||||||||
Non small cell lung cancer (~85%)
| |||||||||||||||
WHO Histological Classification of Tumors of the Lung
The World Health Organization (WHO) classifies tumors of the lungs as follows:[2][1]
WHO Classification of Lung Tumors | |
---|---|
Histological type | Subtype |
Epithelial tumors | |
Adenocarcinoma |
|
Squamous cell carcinoma |
|
Neuroendocrine tumors | |
Small cell carcinoma |
|
Large cell neuroendocrine carcinoma |
|
Carcinoid tumors |
|
'Preinvasive lesion |
|
Large cell carcinoma |
|
Adenosquamous carcinoma |
|
Sarcomatoid carcinomas |
|
Other and Unclassified carcinomas |
|
Salivary gland-type tumors |
|
Papillomas |
|
Adenomas |
|
Mesenchymal tumors | |
Pulmonary hamartoma |
|
Chondroma |
|
PEComatous tumors |
|
Congenital peribronchial myofibroblastic tumor |
|
Diffuse pulmonary lymphangiomatosis |
|
Inflammatory myofibroblastic tumor |
|
Epithelioid hemangioendothelioma |
|
Pleuropulmonary blastoma |
|
Synovial sarcoma |
|
Pulmonary artery intimal sarcoma |
|
Pulmonary myxoid sarcoma with EWSR1–CREB1 translocation |
|
Myoepithelial tumors |
|
Lymphohistiocytic tumors | |
Extranodal marginal zone lymphomas of mucosa-associated Lymphoid tissue (MALT lymphoma) |
|
Diffuse large cell lymphoma |
|
Lymphomatoid granulomatosis |
|
Intravascular large B cell lymphoma |
|
Pulmonary Langerhans cell histiocytosis |
|
Erdheim–Chester disease |
|
Tumors of ectopic origin | |
Germ cell tumors |
|
Intrapulmonary thymoma |
|
Melanoma |
|
Meningioma, NOS |
|
References
- ↑ 1.0 1.1 Travis, William (2004). Pathology and genetics of tumours of the lung, pleura, thymus, and heart. Lyon: IARC Press. ISBN 9283224183.
- ↑ "www.jto.org".